Public Event Detail
May layoffs hit nearly 7,000, with most cuts from Takeda, BioNTech
Public historical observation from the Merrowstone archive. This page shows event-level context only. Accepted assertions, evidence lineage, and relationship intelligence remain part of the premium research layer.
Historical observations only. No forecasts, recommendations, buy/sell ratings, or portfolio advice.
2026-06-11JNJJohnson & JohnsonAlpha Vantage Newsearnings
Event summary
May 2026 saw a significant spike in biopharma layoffs, with nearly 7,000 employees affected, a 47% increase year-over-year. The majority of these cuts came from Takeda and BioNTech, accounting for 6,360 positions, as they announced plans for streamlining operations and facility closures. Other companies like AbbVie, Amicus Therapeutics, Johnson & Johnson, Novartis, and Valneva also contributed to the workforce reductions, marking a challenging month for the industry.
Attached public signals
Observed outcomes
7d returnPending
30d returnPending
90d returnPending
Relative 90d returnPending